Free coverage check, no obligation
For the phase III clinical program, a total of eight studies were initiated that investigated the efficacy and safety of tirzepatide in comparison to various other established antidiabetic medications in T2D either in monotherapy, combination with metformin as baseline therapy, or metformin and insulin glargine as a baseline
Have you considered taking a GLP-1 receptor agonist
But as Retatrutide is not yet FDA approved, availability will take more time
A regulatory filing (NDA/BLA with the FDA, MAA with the EMA) would follow compilation of the complete clinical data package after Phase 3 completion
But for most people, going off the medication allows hunger and appetite to return, sometimes with a vengeance